triiodothyronine has been researched along with Familial Hypokalemic Periodic Paralysis in 3 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Pertinent history revealed that he took drugs containing triiodothyronine (64 mug) and propranolol (40 mg) twice daily for weight reduction in the past month and discontinued these drugs 3 days before admission." | 3.75 | An unusual cause of thyrotoxic periodic paralysis: triiodothyronine-containing weight reducing agents. ( Chou, HK; Lin, SH; Tsao, YT, 2009) |
| "Thyrotoxic hypokalemic periodic paralysis (TPP) is characterized by acute attacks of weakness, hypokalemia, and thyrotoxicosis of various etiologies." | 1.36 | Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. ( Bernstein, HS; Brown, RH; Cheah, JS; da Silva, MR; Donaldson, MR; Fontaine, B; Ho, SC; Jongjaroenprasert, W; Khoo, DH; Kung, AW; Liang, MC; Maciel, RM; Ptácek, LJ; Ryan, DP; Soong, TW, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chou, HK | 1 |
| Tsao, YT | 1 |
| Lin, SH | 1 |
| Ryan, DP | 1 |
| da Silva, MR | 1 |
| Soong, TW | 1 |
| Fontaine, B | 1 |
| Donaldson, MR | 1 |
| Kung, AW | 1 |
| Jongjaroenprasert, W | 1 |
| Liang, MC | 1 |
| Khoo, DH | 1 |
| Cheah, JS | 1 |
| Ho, SC | 1 |
| Bernstein, HS | 1 |
| Maciel, RM | 1 |
| Brown, RH | 1 |
| Ptácek, LJ | 1 |
| Tran, HA | 1 |
3 other studies available for triiodothyronine and Familial Hypokalemic Periodic Paralysis
| Article | Year |
|---|---|
An unusual cause of thyrotoxic periodic paralysis: triiodothyronine-containing weight reducing agents.
Topics: Adult; Humans; Hypokalemic Periodic Paralysis; Male; Propranolol; Substance Withdrawal Syndrome; Thy | 2009 |
Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis.
Topics: Amino Acid Sequence; Base Sequence; DNA Mutational Analysis; Electrophysiological Phenomena; Genetic | 2010 |
Thyrotoxic periodic paralysis.
Topics: Adult; Diagnosis, Differential; Female; Humans; Hypokalemic Periodic Paralysis; Muscle Weakness; Par | 2005 |